Patients with delirium (N = 31) | Patients without delirium (N = 113) | P value | |
---|---|---|---|
Ex vivo stimulation | |||
TNFα, pg/103 monocytes | 1.76 (1.47–2.32) | 3.17 (2.31–4.42) | < 0.01 |
IP-10, pg/103 monocytes | 0.17 (0.10–0.46) | 0.56 (0.32–0.92) | < 0.01 |
IL-1β, pg/103 monocytes | 1.12 (0.62–1.78) | 1.85 (1.26–2.61) | < 0.01 |
IL-6, pg/103 monocytes | 10.37 (8.55–14.52) | 14.21 (9.81–18.16) | 0.02 |
IL-12, pg/106 monocytes | 0 (0–0) | 1.46 (0–8.57) | < 0.01 |
IL-10, pg/106 monocytes | 66.58 (39.57–86.54) | 59.70 (36.85–99.02) | 0.82 |
IL-8, pg/103 monocytes | 2.03 (1.51–2.93) | 1.64 (1.08–2.56) | 0.13 |
TNFα, pg/mL | 2066 (1578–2550) | 2404 (1555–3869) | 0.03 |
IP-10, pg/mL | 166.97 (108.45–366.40) | 436.10 (201.28–797.10) | < 0.01 |
IL-1β, pg/mL | 1153 (680–1690) | 1325 (1046–2092) | 0.11 |
IL-6, pg/mL | 10,455 (8885–16,362) | 10,407 (7280–13,319) | 0.41 |
IL-12, pg/mL | 0 (0–0) | 1.48 (0–6.91) | < 0.01 |
IL-10, pg/mL | 69.23 (36.67–103.38) | 46.62 (31.99–72.11) | 0.06 |
IL-8, pg/mL | 2240 (1469–3209) | 1279 (872–2055) | < 0.01 |
Plasma | |||
TNFα, pg/ml | 0.91 (0.53–1.27) | 0.70 (0.36–1.12) | 0.09 |
IL-6, pg/mL | 17.95 (7.09–46.75) | 3.94 (2.21–7.29) | < 0.01 |